you are here:

Aarti Drugs Ltd.

BSE: 524348 | NSE: AARTIDRUGS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE767A01016 | SECTOR: Pharmaceuticals

BSE Live

Oct 26, 13:44
638.00 3.65 (0.58%)
Volume
AVERAGE VOLUME
5-Day
22,633
10-Day
22,143
30-Day
24,772
26,605
  • Prev. Close

    634.35

  • Open Price

    637.00

  • Bid Price (Qty.)

    637.30 (3)

  • Offer Price (Qty.)

    638.00 (222)

NSE Live

Oct 26, 13:44
638.45 4.40 (0.69%)
Volume
AVERAGE VOLUME
5-Day
244,410
10-Day
206,772
30-Day
217,746
235,860
  • Prev. Close

    634.05

  • Open Price

    636.70

  • Bid Price (Qty.)

    637.95 (23)

  • Offer Price (Qty.)

    638.40 (5)

Financials

2020 2019 2018 2017 2016
Yearly Results of Aarti Drugs (in Rs. Cr.) Mar '21 Mar '20 Mar '19 Mar '18 Mar '17  
Net Sales/Income from operations 1,914.89 1,634.92 1,454.25 1,140.46 1,088.72  
Other Operating Income -- -- -- -- 3.54  
Total Income From Operations 1,914.89 1,634.92 1,454.25 1,140.46 1,092.26  
EXPENDITURE  
Consumption of Raw Materials 1,127.79 1,078.80 930.14 745.65 678.06  
Purchase of Traded Goods 43.17 40.53 32.62 25.97 18.30  
Increase/Decrease in Stocks -9.08 -53.94 19.05 -55.60 3.66  
Power & Fuel -- -- -- -- --  
Employees Cost 69.29 60.10 53.14 50.49 48.72  
Depreciation 47.60 46.67 40.39 37.80 36.69  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 282.44 265.03 220.01 192.10 165.81  
P/L Before Other Inc. , Int., Excpt. Items & Tax 353.68 197.73 158.90 144.05 141.02  
Other Income 6.42 1.06 6.28 1.17 --  
P/L Before Int., Excpt. Items & Tax 360.10 198.79 165.18 145.22 141.02  
Interest 22.61 32.20 37.56 33.01 34.48  
P/L Before Exceptional Items & Tax 337.49 166.59 127.62 112.21 106.54  
Exceptional Items 0.22 8.38 -- -- --  
P/L Before Tax 337.71 174.97 127.62 112.21 106.54  
Tax 80.00 39.30 40.36 38.80 32.30  
P/L After Tax from Ordinary Activities 257.71 135.67 87.26 73.41 74.24  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 257.71 135.67 87.26 73.41 74.24  
Equity Share Capital 93.20 23.30 23.58 23.58 23.86  
Reserves Excluding Revaluation Reserves 766.41 598.49 494.99 409.59 363.11  
Equity Dividend Rate (%) 25.00 20.00 10.00 10.00 10.00  
EPS Before Extra Ordinary  
Basic EPS 27.65 58.12 37.42 30.67 30.78  
Diluted EPS 27.65 58.12 37.42 30.67 30.78  
EPS After Extra Ordinary  
Basic EPS. 27.65 58.12 37.42 30.67 30.78  
Diluted EPS. 27.65 58.12 37.42 30.67 30.78  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited